Research by Indian scientists for the vaccine has now reached the level of animal trials. This test will start in a week or two. After success in this, it will be tested on humans. Seven to eight scientific groups of the country are leading in vaccine research. Scientists from half a dozen educational institutions are also involved in vaccine studies.
Indian scientists may take 12 to 18 months for complete success. 75 teams of scientists worldwide are involved in the vaccine. A senior official said that the vaccine, made in any country, will be produced in India. According to the information, scientists of some companies including Bharat Biotech, Cadila, Serum Institute have reached animal trials. On the instructions of Prime Minister Narendra Modi, the researches started in the country are being monitored by Dr. Renu Swaroop, Secretary, Department of Biotechnology. Ongoing research on virus breeding
According to the ministry, studies on Corona have started in India. After entering the body, the virus rapidly produces other viruses and starts to spread manifold.
The group was formed two years ago…
According to a senior scientist, about two years ago a group of industrial and academic scientists from all over the world was formed, in which India also has participation. In this way, preparations for the vaccine used at the time of the epidemic were also being worked on.
The Indo-US vaccine program also benefits ...
Cooperation on the research between Indo-American scientists has been going on for almost 30 years. India recently made hydroxychloroquine (HCQ) available to the US.
IIT Guwahati signed an agreement for vaccine
IIT Guwahati has tied up with Ahmedabad-based biosciences company Hester for the Corona vaccine. Its trial on animals will begin by the end of the year. Recombinant avian paramyxovirus-1 will work for the vaccine that contains the protein of SARS-COVID-2.
Sachin Kumar, Associate Professor of the Department of Biosciences and Bioengineering, said that it is too early to say anything on this vaccine. Only after the results of its testing on animals can be said.
Successful in Oxford on monkeys, now trial on 6 thousand humans
Scientists at the Jenner Institute at Oxford University in Britain claim that the clinical trial of the vaccine on monkeys has been successful. Now, by the end of May, they will also test on six thousand humans. Then the vaccine may enter the market by September this year after emergency approval from the regulators. Oxford University tested the vaccine on six macaque monkeys at the Rocky Mountain Lab of the National Institutes of Health in Montana in March. This species of monkeys are considered to be closest to humans.
Monkey found healthy even after 28 days…
Dr. Vincent Munstavar said, 28 days later six monkeys with the vaccine were found healthy, while the other monkeys became ill. However, some experts are saying that the formation of antibodies in monkeys does not guarantee the same in humans. But the results certainly increased the enthusiasm to take the trial to the next stage.
The Pune institute is also involved in research ...
Serum Institute of India is also involved in this research. The serum is the largest vaccine supplier in the world. The vaccine will be produced in the serum itself.
Rajasthan Tourism App - Welcomes to the land of Sun, Sand and adventures